Skip to content
DraconiticResearch
Search Sources API
220,595 studies31 sourcesUpdated 54 min ago
Peer-reviewedLicence not statedChinese Journal of Cancer Research

A patient-derived bladder cancer organoid and xenograft platform for personalized drug response prediction and salvage therapeutics screening

  • Junlin Lu1,2
  • Kaiwen Jie1,2
  • Chu Liu1,2
  • Jiajian Lai1,2
  • Peng Xu3
  • Xinxin He4
  • Kanghua Xiao5
  • Yating Chen6
  • Sen Liu1,2
  • Zehua Chen1,2
  • Jianhui Zhang1,2
  • Zegeng Yang1,2
9 more authors
  • Shizhi Lin1,2
  • Qiang Zhang1,2
  • Ming Huang1,2
  • Liang Cheng1,2
  • Siting Chen1,2
  • Jianmei Zhong1,2
  • Sheng Li6
  • Hong Li6
  • Xu Chen1,2
6 affiliations
  1. 1Department of Urology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou 510120, China
  2. 2Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou 510120, China
  3. 3Department of Urology, Zhujiang Hospital, Southern Medical University, Guangzhou 510280, China
  4. 4Department of Pathology, Sun Yat-sen Memorial Hospital of Sun Yat-sen University, Guangzhou 510120, China
  5. 5Department of Urology, the First Affiliated Hospital of Guangzhou Medical University, Guangdong Provincial Key Laboratory of Urological Diseases, Guangdong Engineering Research Center of Urinary Minimally Invasive Surgery Robot and Intelligent Equipment, Guangzhou Institute of Urology, Guangzhou 510120, China
  6. 6BioMed Laboratory, Jingke Biotechnology Group, Bioisland International, Guangzhou 510005, China
Read full textDOICite

Related

  1. Optimization of a Subcutaneous Epithelioid Hemangioendothelioma Xenograft Model for Evaluation of Preclinical Therapeutics
    Z. Chen, L. Wang, V. Zuco +5
    bioRxivPreprintCC BY-NC-NDFull textOncologybioRxiv
  2. Organoid-Guided Synthetic Micropeptide Therapeutics to Target Ovarian Cancer Stem Cells
    Bhavana Balayoganandh, Naisarg Gamit, Harshit Kallepalli +3
    CancersPeer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMC
  3. Personalized prediction of sequential therapeutic responses in HR+/HER2-low breast cancer using patient-derived organoids
    Wei Zhao, Zhongni Wu, Chengpan Li +13
    Translational cancer researchPeer-reviewedCC BY-NC-NDFull textGeneral medicineEurope PMC
  4. Evolving practices in pretransplant cardiovascular screening: moving toward personalized assessments
    Arzu Velioglu, Tansu Celik, Harun Coban +3
    Clinical kidney journalPeer-reviewedCC BY-NCFull textMedical imaging & radiologyEurope PMCEurope PMCPMC
  5. Knowledge Graphs for Cervical Cancer Across the Care Continuum: From Vaccination and Screening to Personalized Therapy.
    Jiyan Leng, Wenzhi Wei, Xiaohua Wen +2
    Therapeutics and clinical risk managementPeer-reviewedCC BY-NCFull textEpidemiology & public healthEurope PMC

Cite

BibTeXRIS
BibTeX
@article{lu2026patientderived,
  title = {{A patient-derived bladder cancer organoid and xenograft platform for personalized drug response prediction and salvage therapeutics screening}},
  author = {Junlin Lu and Kaiwen Jie and Chu Liu and Jiajian Lai and Peng Xu and Xinxin He and Kanghua Xiao and Yating Chen and Sen Liu and Zehua Chen and Jianhui Zhang and Zegeng Yang and Shizhi Lin and Qiang Zhang and Ming Huang and Liang Cheng and Siting Chen and Jianmei Zhong and Sheng Li and Hong Li and Xu Chen},
  journal = {Chinese Journal of Cancer Research},
  year = {2026},
  month = oct,
  doi = {10.21147/j.issn.1000-9604.2026.05.11},
  url = {https://doi.org/10.21147/j.issn.1000-9604.2026.05.11},
}
RIS
TY  - JOUR
TI  - A patient-derived bladder cancer organoid and xenograft platform for personalized drug response prediction and salvage therapeutics screening
AU  - Junlin Lu
AU  - Kaiwen Jie
AU  - Chu Liu
AU  - Jiajian Lai
AU  - Peng Xu
AU  - Xinxin He
AU  - Kanghua Xiao
AU  - Yating Chen
AU  - Sen Liu
AU  - Zehua Chen
AU  - Jianhui Zhang
AU  - Zegeng Yang
AU  - Shizhi Lin
AU  - Qiang Zhang
AU  - Ming Huang
AU  - Liang Cheng
AU  - Siting Chen
AU  - Jianmei Zhong
AU  - Sheng Li
AU  - Hong Li
AU  - Xu Chen
PY  - 2026
DA  - 2026/10/30
JO  - Chinese Journal of Cancer Research
DO  - 10.21147/j.issn.1000-9604.2026.05.11
UR  - https://doi.org/10.21147/j.issn.1000-9604.2026.05.11
SN  - 1000-9604
SN  - 1993-0631
ER  -